After Sputnik V, Russia approves second COVID-19 vaccine Epivaccorona


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ After Sputnik V, Russia approves second COVID-19 vaccine Epivaccorona
Epivaccorona is developed by the Vector State Research Centre of Virology and Biotechnology.

Russia has granted regulatory approval to a second COVID-19 vaccine, President Vladimir Putin announced on Wednesday, adding that the country needed to ramp up the production of both the first and second vaccines.

Russia became the first country to give regulatory approval to a COVID-19 vaccine in August when Sputnik V has officially registered ahead of a large-scale clinical trial, drawing criticism from some quarters in the scientific community. The second Russian vaccine to get regulatory approval has been developed by the Vector State Research Centre of Virology and Biotechnology.

"We need to increase the production of the first and second vaccine. We are continuing to cooperate with our foreign partners and will promote our vaccine abroad," Putin was quoted by Reuters as saying.


Vector's vaccine, dubbed "EpiVacCorona", relies on chemically synthesized peptide antigens of SARS-CoV-2 proteins, conjugated to a carrier protein and adsorbed on an aluminium-containing adjuvant, according to details posted at ClinicalTrials.gov, a database of privately and publicly funded clinical studies conducted around the world.

Putin said that a third Russian vaccine against Covid-19, developed by the Chumakov Centre, would also be registered in the near future, Sputnik news agency reported.

Russian Deputy Prime Minister Tatyana Golikova said that she tested EpiVacCorona vaccine herself and experienced no side effects, said the report.

"The Vector centre is also initiating post-registration clinical trials in the various regions of Russia that would include 40,000 volunteers," she was quoted as saying.

The announcement of the second COVID-19 vaccine came as the country recorded a record daily increase in coronavirus cases and switched to online classes for a secondary school in the capital.

Unlike Western countries, Russia has given official approval to its COVID-19 vaccines without waiting for the results of large-scale trials in thousands of patients, which are normally required to prove that a drug is safe and effective. That decision has been criticised by scientists in other countries.

Tags : #SputnikV #Epivaccorona #SecondCovidVaccine #VectorStateResearchCentreofVirologyandBiotechnology #TatyanaGolikova #VladimirPutin #SecondRussianVaccine

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026